Clinical Trial Update: Aponermin, Pomalidomide, Dexamethasone for Patients With Relapsed/ Refractory Multiple Myeloma [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating a combination of Aponermin, pomalidomide, and dexamethasone in relapsed or refractory multiple myeloma, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Aponermin (aponermin)
• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalyst) (pomalidomide)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Multiple Myeloma, Neoplasms | NA | Status: ACTIVE_NOT_RECRUITING